SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-019138
Filing Date
2023-05-25
Accepted
2023-05-25 17:22:09
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 858081
2 ex31-1.htm EX-31.1 11311
3 ex31-2.htm EX-31.2 11706
4 ex32-1.htm EX-32.1 6503
5 ex32-2.htm EX-32.2 6528
  Complete submission text file 0001493152-23-019138.txt   4663174

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT shph-20230331.xsd EX-101.SCH 31676
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT shph-20230331_cal.xml EX-101.CAL 49393
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT shph-20230331_def.xml EX-101.DEF 180420
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT shph-20230331_lab.xml EX-101.LAB 304976
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT shph-20230331_pre.xml EX-101.PRE 248762
51 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 663391
Mailing Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850
Business Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850 2404034212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41488 | Film No.: 23962059
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences